Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

desferrioxamine-loaded nanoparticles

Based on

1 Articles
2011 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

poly(ε-caprolactone)- block-poly(propylene adipate) copolymer

poly(propylene adipate)-block-poly(ε-caprolactone) copolymer PPAd-block-PCL copolymer PPAd/PCL 10/90
Type Polymer
Formula
Role carriers
2

desferrioxamine B

desferrioxamine deferoxamine DFOB DFO
Type Single Compound
Formula C25H48N6O8
Role loaded material

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
desferrioxamine release

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • desferrioxamine B
  1. h6GGf13WpHwOVN
Product

desferrioxamine-loaded nanoparticles

Size: not specified

Medium/Support: none

Method 2

Type: Physical formation
Source:
Product

desferrioxamine-loaded nanoparticles

Diameter: 228.54 - 235.46 nm

Medium: water

Support: none

Method 3

Type: Physical formation
Source:
Product

desferrioxamine-loaded nanoparticles

Diameter: 168.75 - 173.25 nm

Medium: water

Support: none

Method 4

Type: Physical formation
Source:
Product

desferrioxamine-loaded nanoparticles

Diameter: 173.18 - 178.82 nm

Medium: water

Support: none

Method 5

Type: Physical formation
Source:
Starting materials
  • desferrioxamine B
  1. tQKkv2htRgFGzC
Product

desferrioxamine-loaded nanoparticles

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial